85.29
0.90%
0.76
After Hours:
85.29
Globus Medical Inc stock is traded at $85.29, with a volume of 682.63K.
It is up +0.90% in the last 24 hours and up +16.56% over the past month.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.
See More
Previous Close:
$84.53
Open:
$84.85
24h Volume:
682.63K
Relative Volume:
0.87
Market Cap:
$11.51B
Revenue:
$2.48B
Net Income/Loss:
$91.51M
P/E Ratio:
42.43
EPS:
2.01
Net Cash Flow:
$293.77M
1W Performance:
+2.03%
1M Performance:
+16.56%
6M Performance:
+29.58%
1Y Performance:
+85.13%
Globus Medical Inc Stock (GMED) Company Profile
Name
Globus Medical Inc
Sector
Industry
Phone
610-930-1800
Address
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
85.29 | 11.51B | 2.48B | 91.51M | 293.77M | 2.01 |
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-07-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
May-20-24 | Upgrade | Piper Sandler | Neutral → Overweight |
Mar-18-24 | Upgrade | BTIG Research | Neutral → Buy |
Oct-20-23 | Initiated | ROTH MKM | Buy |
Sep-19-23 | Upgrade | Stifel | Hold → Buy |
Mar-30-23 | Upgrade | Canaccord Genuity | Hold → Buy |
Feb-13-23 | Downgrade | BofA Securities | Buy → Underperform |
Feb-10-23 | Downgrade | BTIG Research | Buy → Neutral |
Feb-10-23 | Downgrade | Loop Capital | Buy → Hold |
Feb-10-23 | Downgrade | Needham | Buy → Hold |
Feb-10-23 | Downgrade | Truist | Buy → Hold |
Feb-10-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Oct-18-22 | Initiated | Barclays | Overweight |
Oct-12-22 | Initiated | Jefferies | Buy |
Apr-13-22 | Resumed | Truist | Buy |
Mar-28-22 | Initiated | Wells Fargo | Overweight |
Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
Dec-13-21 | Upgrade | BofA Securities | Underperform → Buy |
Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
Oct-29-21 | Initiated | Loop Capital | Buy |
Feb-18-21 | Resumed | Needham | Buy |
Dec-08-20 | Initiated | Citigroup | Buy |
Oct-20-20 | Initiated | Stifel | Hold |
Aug-06-20 | Reiterated | Needham | Buy |
Aug-06-20 | Upgrade | Northland Capital | Market Perform → Outperform |
Jul-21-20 | Initiated | Northland Capital | Market Perform |
Jul-06-20 | Downgrade | Piper Sandler | Overweight → Neutral |
May-08-20 | Reiterated | Needham | Buy |
Mar-18-20 | Upgrade | BTIG Research | Neutral → Buy |
Jan-08-20 | Initiated | SunTrust | Buy |
Dec-12-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
Aug-02-19 | Reiterated | Needham | Buy |
May-24-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
May-03-19 | Reiterated | Needham | Buy |
Feb-28-19 | Upgrade | UBS | Neutral → Buy |
Jan-02-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Aug-02-18 | Reiterated | Needham | Buy |
Jun-27-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
Jun-01-18 | Initiated | Cantor Fitzgerald | Overweight |
May-03-18 | Reiterated | Needham | Buy |
Apr-04-18 | Upgrade | Needham | Hold → Buy |
View All
Globus Medical Inc Stock (GMED) Latest News
GMED (Globus Medical) Operating Cash Flow per Share : $3.02 (TTM As of Sep. 2024) - GuruFocus.com
GMED (Globus Medical) Revenue : $2,479 Mil (TTM As of Sep. 2024) - GuruFocus.com
GMED (Globus Medical) Land And Improvements : $10 Mil (As of Sep. 2024) - GuruFocus.com
Swedbank AB Has $28.62 Million Stock Position in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Massachusetts Financial Services Co. MA Buys Shares of 369,102 Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Globus Medical, Inc. (NYSE:GMED) Shares Acquired by Intech Investment Management LLC - MarketBeat
Globus Medical director David Davidar sells shares for $3.4 million By Investing.com - Investing.com Australia
Globus Medical's SWOT analysis: stock soars on merger synergies, FDA hurdles loom - Investing.com
Globus Medical CEO Scavilla sells $11.05 million in stock By Investing.com - Investing.com Australia
Globus Medical CEO Scavilla sells $11.05 million in stock - Investing.com
Globus Medical director David Davidar sells shares for $3.4 million - Investing.com
GMED (Globus Medical) Peter Lynch Fair Value : $28.96 (As of Nov. 25, 2024) - GuruFocus.com
GMED Stock Might Rise From the Commercial Launch of Its ExcelsiusHub - Yahoo Finance
GMED (Globus Medical) Operating Income : $169 Mil (TTM As of Sep. 2024) - GuruFocus.com
Quest Partners LLC Invests $523,000 in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Eagle Asset Management Inc. Purchases 29,573 Shares of Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Globus Medical, Inc. (NYSE:GMED) Receives $88.18 Consensus PT from Analysts - MarketBeat
Globus Medical Launches ExcelsiusHub™ Navigation System - The Manila Times
Globus Medical, Inc. (GMED) Hit a 52 Week High, Can the Run Continue? - MSN
Globus Medical stock soars to all-time high of $84.89 By Investing.com - Investing.com Canada
GMED (Globus Medical) 50-Day SMA : $74.46 (As of Nov. 22, 2024) - GuruFocus.com
Globus Medical stock soars to all-time high of $84.89 - Investing.com
Options Movement At Globus Medical: David Paul Exercises Worth $1.55M - Benzinga
Overlook Medical Center Adds ExcelsiusGPS™ Robotic Navigation System to Enhance Spine Surgeries - TAPinto.net
Overlook Medical Center adds ExcelsiusGPS™ robotic navigation system to enhance spine surgeries - TAPinto.net
Aurora Investment Counsel Lowers Position in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Orthopedic Anchor Market Overall Study Report 2024-2032 | - openPR
GMED (Globus Medical) LT-Debt-to-Total-Asset : 0.02 (As of Sep. 2024) - GuruFocus.com
Is Globus Medical (GMED) a Solid Growth Stock? 3 Reasons to Think "Yes" - MSN
Globus Medical (MEX:GMED) Asset Turnover : 0.13 (As of Sep. 2024) - GuruFocus.com
Globus Medical (GMED) is a Top-Ranked Momentum Stock: Should You Buy? - MSN
Global Alpha Capital Management Ltd. Has $63.32 Million Holdings in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term - MSN
Segall Bryant & Hamill LLC Buys 26,047 Shares of Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Globus Medical (NYSE:GMED) Downgraded by StockNews.com to Hold - MarketBeat
Globus Medical Boosts 2024 Outlook For Third Time, Stock Hits All-Time High - RTTNews
Thrivent Financial for Lutherans Sells 29,106 Shares of Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Globus Medical Stock: Re-Rated After A Solid Year (NYSE:GMED) - Seeking Alpha
Globus Medical, Inc. (NYSE:GMED) Shares Sold by Vaughan Nelson Investment Management L.P. - MarketBeat
Principal Financial Group Inc. Decreases Position in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Janus Henderson Group PLC Adjusts Stake in Globus Medical Inc - GuruFocus.com
Expanding Global Market, NuVasive Benefits to Aid GMED Stock - MSN
Globus Medical's SWOT analysis: robotic surgery drives stock growth By Investing.com - Investing.com Nigeria
Globus Medical's SWOT analysis: robotic surgery drives stock growth - Investing.com
Globus Medical price target raised to $83 from $74 at Morgan Stanley - Yahoo Finance
Some May Be Optimistic About Globus Medical's (NYSE:GMED) Earnings - Yahoo Finance
Globus Medical (GMED) is a Top-Ranked Growth Stock: Should You Buy? - Yahoo Canada Finance
Globus Medical, Inc. (NYSE:GMED) Shares Purchased by Lisanti Capital Growth LLC - MarketBeat
Globus Medical (NYSE:GMED) Price Target Raised to $83.00 - MarketBeat
Insider Selling: Globus Medical, Inc. (NYSE:GMED) SVP Sells 5,000 Shares of Stock - MarketBeat
Globus Medical, Inc. (NYSE:GMED) CEO Daniel T. Scavilla Sells 60,000 Shares - MarketBeat
Globus Medical Inc Stock (GMED) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):